KATHLEEN REGAN: Open Payments
NPI 1639117989 · STANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$967 in 45 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $967
Food & beverage: $967
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 14 | $185 |
| Merck Sharp & Dohme LLC | 4 | $110 |
| Celgene Corporation | 3 | $99 |
| AstraZeneca Pharmaceuticals LP | 3 | $83 |
| GlaxoSmithKline, LLC. | 2 | $54 |
| Lilly USA, LLC | 2 | $47 |
| ABBVIE INC. | 2 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Legend Biotech USA Inc. | 2 | $41 |
| Caris MPI, Inc. | 2 | $41 |
Products named: INJECTAFER, KEYTRUDA, Enhertu, OPDIVO, VERZENIO, CARVYKTI, MI CANCER SEEK, Yescarta.
Industry payments across CA — which companies pay providers there.
